Phiome
PrivateLast Round
Series D
Sep 10, 2024
Total Funding Raised
$303.5M
Company Overview
Phiome is a biotechnology company that specializes in odour preventative technology using microbiome-smart ingredients for cosmetic and textile applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Fashion & Beauty, D2C Brands
Business Model
B2C
Customer Profile
Hardware Sales, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Phiome Comparables
Compare Phiome with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AOBiome Therapeutics Inc. | 71% | |
| Arcaea | 70% | |
| Beiersdorf | 70% | |
Phiome Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Sep 10, 2024 | ||||
| Series C Extension | Aug 18, 2023 | ||||
| Series C Extension | Oct 18, 2022 | ||||
| Convertible Debt | Nov 10, 2021 | ||||
| Series B | Nov 1, 2019 | ||||
Series A | Aug 2, 2017 |
Phiome Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ocgrow Ventures | Convertible Debt, Series C Extension |
| Ezaki Glico Co., Ltd. | Convertible Debt, Series B, Series C Extension |
| Khosla Ventures | Convertible Debt, Series B, Series C Extension, Series D, Series A |
| WestRiver Group | Series B |
| BOLD Capital Partners | Convertible Debt, Series B, Series D, Series A, Series C Extension |
| WestRiver Group | Convertible Debt, Series C Extension, Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 10, 2024
$25M round with Khosla Ventures and BOLD Capital Partners.
- Aug 18, 2023
$87M round led by Khosla Ventures and BOLD Capital Partners.
Phiome Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Phiome's valuation, stock price, and market status.